Amphotericin B-albumin conjugates: Synthesis, toxicity and anti-fungal activity
- 1 March 2018
- journal article
- research article
- Published by Elsevier in European Journal of Pharmaceutical Sciences
- Vol. 115, 167-174
Abstract
No abstract availableKeywords
This publication has 44 references indexed in Scilit:
- Galactomannan–amphotericin B conjugate: synthesis and biological activityPolymers for Advanced Technologies, 2010
- Injectable in situ cross-linking hydrogels for local antifungal therapyBiomaterials, 2010
- N-(2-hydroxypropyl)methacrylamide–amphotericin B (HPMA–AmB) copolymer conjugates as antileishmanial agentsInternational Journal of Antimicrobial Agents, 2009
- Albumin as a drug carrier: Design of prodrugs, drug conjugates and nanoparticlesJournal of Controlled Release, 2008
- Spectroscopic Investigation of the Interaction of BSA with Cationic SurfactantsChemical Engineering & Technology, 2008
- Amphotericin B Formulations and Drug TargetingJournal of Pharmaceutical Sciences, 2008
- Multidrug Resistance in FungiEukaryotic Cell, 2007
- Mortality and Costs of Acute Renal Failure Associated with Amphotericin B TherapyClinical Infectious Diseases, 2001
- Reduced Amphotericin Toxicity in an Albumin VehicleJournal of Drug Targeting, 1993
- Ambiguities in IR and X-Ray Characterization of Amphotericin BJournal of Pharmaceutical Sciences, 1978